Microsoft Axapta for Life Sciences

  • Source: Microsoft
  • Written By:
  • Published:
  • (Originally Published On:) )
Executives in the life sciences industry work under tremendous competitive pressures. At the same time, they must meet regulatory guidelines and ensure that product safety remains a priority. Information must be meticulously tracked through all phases of a production cycle, which can slow production significantly. That’s why solutions for the industry must help streamline and simplify the regulatory compliance process.

Featured Software Research:

Databases and ERP Selection: Oracle vs. SQL Server

  • Source: IFS
  • Written By:
  • Published:
The database is an essential component of enterprise applications such as enterprise resource planning (ERP) and enterprise asset management (EAM). This white paper outlines the advantages and disadvantages of the Oracle and Microsoft SQL Server database platforms. How do the two compare when it comes to reliability, scalability, and total cost of ownership (TCO) when integrated with enterprise software? Read More

Selecting ERP for Oil and Gas Industry Contractors and Vendors

  • Source: IFS
  • Written By:
  • Published:
Suppliers to the oil and gas industry are under more pressure than ever before to increase quality, collaborate closely with the customer, and take on more project risk. Learn how enterprise resource planning (ERP) helps engineers procure construction companies, equipment fabricators, and service providers to meet the new demands from oil and gas companies. Download this white paper to learn more. Read More

You may also be interested in these related documents:

Why Life Sciences Companies Should Engage on Social Media

While most industries are rapidly adopting social media to engage with customers, the life sciences companies remain typically balk at extending social presence in a highly regulated environment. In view of recent Food and Drug Administration (FDA) guidelines on the responsibilities of life sciences companies monitoring social media, this paper intends to assist life sciences companies in determining the scope and potential impact of creating a social media engagement program. Read More

Health Means More

Medical and health care regulatory norms are tightening worldwide, and all key stakeholders, including payers, providers, and patients are becoming more discerning with regard to the quality of products and services delivered. As a result, the health care and life sciences (HLS) sector is increasingly leaning on analytics to find solutions for improving the delivery of health care—and improving the business of health care. Read More

The State of Global Clinical Research Trials

New technologies and changing economic conditions have triggered a number of changes in the pharmaceuticals, life sciences, and biotech sectors. Increased global sales of life sciences products and growing demand for drugs present drug industry companies with a host of opportunities. However, the mandate for clinical trials has led to considerable inflation in their research and development (R&D) expenditure. The resolution lies in using emerging markets as an alternative to conduct these trials.... Read More
 
comments powered by Disqus